Evidence map›Paper›PMID 29357360›Full record

ArticlePLoS genetics2018

Signalling crosstalk during early tumorigenesis in the absence of Polycomb silencing.

Jorge V Beira, Joana Torres, Renato Paro

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Frontiers in pharmacology · 2025
    Article
  2. Epigenetic Regulation in Drosophila Tumor Models.Advances in experimental medicine and biology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Size compensation inFrontiers in cell and developmental biology · 2023
    Article
  8. Article
  9. Ursolic Acid Protects Sodium Dodecyl Sulfate-InducedAntioxidants (Basel, Switzerland) · 2022
    Article
  10. Tumorigenesis and cell competition inProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Article
  12. PHF19 inhibition as a therapeutic target in multiple myeloma.Current research in translational medicine · 2021
    Article
  13. Article
  14. Article
  15. Two-Faced: Roles of JNK Signalling During Tumourigenesis in theFrontiers in cell and developmental biology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jorge V BeiraETH Zürich, Department of Biosystems Science and Engineering, MattenstrasseBasel, Switzerland.ORCID 0000-0002-2884-4964
Joana TorresETH Zürich, Department of Biosystems Science and Engineering, MattenstrasseBasel, Switzerland.
Renato ParoETH Zürich, Department of Biosystems Science and Engineering, MattenstrasseBasel, Switzerland.
ETH Zurich · CHUniversity of Basel · CH

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
NIH HHS P40 OD018537
6 · The paper itself

Abstract

In response to stress and injury a coordinated activation of conserved signalling modules, such as JNK and JAK/STAT, is critical to trigger regenerative tissue restoration. While these pathways rebuild homeostasis and promote faithful organ recovery, it is intriguing that they also become activated in various tumour conditions. Therefore, it is crucial to understand how similar pathways can achieve context-dependent functional outputs, likely depending on cellular states. Compromised chromatin regulation, upon removal of the Polycomb group member polyhomeotic, leads to tumour formation with ectopic activation of JNK signalling, mediated by egr/grnd, in addition to JAK/STAT and Notch. Employing quantitative analyses, we show that blocking ectopic signalling impairs ph tumour growth. Furthermore, JAK/STAT functions in parallel to JNK, while Notch relies on JNK. Here, we reveal a signalling hierarchy in ph tumours that is distinct from the regenerative processes regulated by these pathways. Absence of ph renders a permissive state for expression of target genes, but our results suggest that both loss of repression and the presence of activators may collectively regulate gene expression during tumorigenesis. Further dissecting the effect of signalling, developmental or stress-induced factors will thus elucidate the regulation of physiological responses and the contribution of context-specific cellular states.

Indexed as

AnimalsAnimals, Genetically ModifiedCarcinogenesisDrosophila melanogasterEmbryo, NonmammalianGene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticGene SilencingHumansJanus KinasesMAP Kinase Signaling SystemNeoplasmsPolycomb-Group ProteinsReceptor Cross-TalkReceptors, NotchSignal TransductionJanus KinasesPolycomb-Group ProteinsReceptors, NotchSTAT Transcription Factors

Identifiers

PMID29357360
PMCPMC5794193
OpenAlexW2785056002

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.